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the primitive crustacean class
Branchipodia, specifically in the
clam shrimp Eulimnadia texana
Populations of these shrimps
comprise males and self-
compatible hermaphrodites.
Previous studies have
suggested that the transition to
androdioecy in the clam shrimp
may have been a rather recent
event. But, because of the ancient
origins of the Branchiopodia,
other have suggested a more
ancient origin.
In the new study, the team has
studied the reproductive
strategies of a number of species
of shrimp within the genus
Eulimnadia from all continents
where they occur. The actual
number of species is currently
debated but thought to be
between 28 and 44. The team
report data on 11 species and find
that nine showed definitive
evidence of androdioecy.
“Because these species
represent a random subset of the
28–44 species of Eulimnadia and
are distributed across all
continents that contain the
shrimp, the most parsimonious
explanation at present for the
preponderance of this breeding
system in Eulimnadia is that it
arose at or before the origin of
this genus,” the authors report.
As widespread recent dispersal
of these shrimps appears unlikely,
the researchers have compared
populations with the history of
continental movements that may
have separated previously closely
associated populations. Such
ancient separations, the authors
believe, have meant that these
clam shrimp have retained
androdioecy through multiple
speciation events and across tens
to hundreds of millions of years,
suggesting “that in this genus,
androdioecy has been a highly
successful and important mode of
reproduction.”
These results throw up fresh
fuel for the theoreticians. “Any
truly comprehensive model
seeking to delineate the benefits
of separation of the sexes relative
to hermaphroditism must now
explain the long-lived coexistence
of males with hermaphrodites in
the Eulimnadia crustacea,” the
authors believe.Book
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Anyone who loves dogs and
makes a living studying genomes
is sure to enjoy a new collection of
reviews entitled ‘The Dog and Its
Genome’. A wide range of topics is
covered, from the role of dogs in a
modern military to clinical trials for
gene therapy, and from genetic
dissection of congenital hip
dysplasia to selection on cognitive
function in silver foxes. The
question is, though, whether or not
someone not so enamored with
dogs is likely to find the subject
matter interesting and compelling.
This question is at the heart of the
matter of whether the recent
completion of the canine genome
sequence will see the domestic
dog take its place alongside the
laboratory mouse as an
indispensable model for human
disease.
I put this question to one of my
own shelties, Paddington. He
looked me straight in the eye and
firmly expressed his opinion that
the real question is whether the
human is a useful model for canine
disease? There are many
indications that it is, but certain
deficiencies of the human system
limit their utility for identification of
susceptibility factors for complex
disease. The first generation of the
canine haplotype map and
increasing interest in canine
genetics suggest that much
progress is to be expected from
direct study of a wide range of
breeds.
The primary advantage of the
dog for mapping complex
diseases is that the two-phase
recent history of the species,involving initial domestication out-
of-Asia approximately 40,000
years ago, followed by very recent
selection of over 200 breeds, has
left a very convenient haplotype
block structure. Within most
breeds, it appears that the
genome can be regarded as a
mosaic of just ten thousand
segments, and this number of
tagging polymorphisms (SNPs)
should be sufficient to conduct a
whole genome scan for
association between genotype and
disease. That is about one tenth
the number required for humans,
though it remains to be seen
whether the density is as
comprehensive as theory
suggests. Subsequently, more
focused sampling across regions
in a collection of breeds promises
to refine 5 Mb intervals to
individual candidate genes, as the
boundaries of haplotype blocks
are thought to vary among breeds.
This scheme is outlined nicely in
the book, in the chapter authored
by Lindblad-Toh and coworkers,
who also provide a more detailed
description of the 7.6X assembly
of the genome of a boxer as well
as initial observations of the
canine hapmap in a recent Nature
paper [1].
It is becoming apparent that the
alleles that promote disease
susceptibility are often unevenly
distributed across human
populations. This presents a
considerable drawback for
association mapping in humans,
because of the so-called
population stratification problem,
and considerably reduces their
utility relative to Canis familiaris.
The breed structure of domestic
dogs not only provides a
framework for study designs that
are relatively unaffected by
admixture, but also takes
advantage of the hypothesis that
most common disease alleles have
been captured by the inbreeding
process. The biggest uncertainty,
common to both dogs and
humans, is genetic heterogeneity:
if different polymorphisms
contribute to disease in different
populations or breeds,
comparisons across these groups
are not informative. But many of
the alleles of interest likely arose
prior to recent breed formation,
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What turned you on to biology in
the first place? As an engineering
student in college, my interests
were drifting from nuclear physics
to chemistry to biochemistry when,
in my third year, I took my first ever
biology class, and suddenly the
‘lights came on’. It was the lac
operon that did it, and genetics
has been my passion ever since.
Believe it or not, I’d never been
exposed to biology previously,
even in high school where the
Jesuit teachers, mainly interested
in philosophy and logic, pointed us
toward mathematics and physics,
and placed a low relative value on
biology. Obviously, this was a
rather unfortunate miscalculation
on their part and I’m sure it robbed
a lot of promising students of an
opportunity to consider a
rewarding and worthwhile career
path in biology. 
Do you have a scientific hero?
Barbara McClintock, because she
never let anything or anybody
stand in the way of pursuing
research that she believed to be
important and worthwhile. Her
love of science, her
openmindedness, and the way
she balanced scientifically
rigorous analysis with intuition
and creative thought have long
been an inspiration to me.
What paper influenced you
most? Unquestionably that would
be R. Alexander Brink’s 1960
article ‘Paramutation and
chromosome organization’ (Q.
Rev. Biol. 35, 120), in which he
proposed that chromosomes have
a ‘paragenetic’ function in additionand the well-known tendency of
particular maladies to show breed-
specificity can be used to infer
likely sharing of descent of the
causative alleles. As made clear in
the volume under review, this is as
true of major-gene diseases such
as copper toxicosis and various
retinopathies, as it is of the more
complex and more prevalent
cardiomyopathies, cancers, and
dermatitis.
Conduction of clinical trials is
also much more difficult in
humans. Human healthcare is
expensive, and members of this
species show a predilection
toward law suits when things don’t
go quite right. By contrast, dog
trials can be relatively quick to
perform, study populations are
fairly easily recruited, and it turns
out the physiology and
endocrinology of disease is often
strikingly similar between the large
mammals. Though not discussed
in the volume, pharmacogenetics
may get a boost from dogs, as
refractoriness to drugs often
displays similar levels as observed
in humans — for example,
veterinarians will tell you that
approximately ten percent of
epileptics are non-responsive to
the commonly used
pharmacological agents — and
there is less of the litigious
downside to mis-prediction. Gene
therapy, too, has definite upsides
in canines as various gene delivery
approaches can be assessed in
dogs for many treatable rare
disorders that can actually be bred
in study colonies.
Why not mice? The simple
answer is that most of the complex
diseases we see in dogs are
naturally occurring, as opposed to
having been engineered into caged
animals. Our pets share our
toxicological and, to some extent,
nutritional environment, and the
similarities in the time of onset and
etiology of so many of the major
diseases is striking. It turns out,
too, that our genomes are more
similar at the level of gene content
and sequence than those of
rodents, even though rodents
share a more recent common
ancestor with Homo sapiens than
do dogs. This is because of an
accelerated rate of divergence in
the smaller mammals.Nevertheless, many biomedical
researchers, particularly those who
serve on study sections, will point
out that there are few remaining
limits to gene discovery in humans,
and what we really need is a model
organism that we can manipulate
genetically in order to test specific
hypotheses. Transgenic dogs
expressing GFP-tagged proteins
aren’t likely to be running around
any time soon — though a dog
with fluorescent green eyes may
go down well with children — while
biochemistry and molecular cell
biology lag well behind the mouse.
Dogs are unlikely ever to become a
model for the annotation of gene
function.
Which brings us back to the
reason why there are dogs in the
first place: they are physically
diverse and attractive, and
behaviorally fascinating and useful.
Another reason to buy The Dog
and its Genome is for the superb
28-page appendix of paintings of
145 breeds. It is remarkable given
the variety of shapes and sizes
how little attention evolutionary
developmental biologists have
given to the species. Aside from a
few groups performing quantitative
trait loci (QTL) mapping within
breeds, there is little data on the
genetic basis of allometric
differentiation, despite the fact that
such studies are likely to provide a
perspective quite distinct from the
one derived from comparison of
invertebrate development [2].
Regarding behavior, dogs are even
more compelling. Whether it is
herding tendencies or separation
anxiety, the neurochemistry of
seizures, or simply the biology of
unconditional love, dogs present
opportunities for study that are
second to none.
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